Research

Name: A Safe, Accessible Treatment for ME/CFS? The Mitochondrial Stabilizer IVO-21 Study
Start: 2026-09-08T15:00:00-07:00
End: 2026-09-08T16:00:00-07:00

October 2025
The Unified Platform: Advancing Research Across ME/CFS, Long Covid, and Other Chronic Conditions

October 14, 2025 @ 3:00 pm - 4:00 pm PDT

Chronic illnesses such as myalgic encephalomyelitis (ME) and Long COVID, which lack clinical biomarkers, present challenges around diagnosis, symptom reporting, and monitoring. That’s why the unhide® Solve Together Unified Platform–which is participant-led with continuous digital data collection–offers some advantages over traditional site-based clinical research models. The easy-to-use, secure platform allows patients to contribute data through […]
January 2026
From Mystery to Measurable: The Science Behind the New ME/CFS Blood Test

January 15 @ 9:00 am - 10:00 am PST

For the first time, scientists have developed a simple, accurate blood test that can potentially identify Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) — a long-term, debilitating condition that affects millions of patients worldwide. The study (published in the Journal of Translational Medicine), led by the University of East Anglia in partnership with Oxford BioDynamics, […]
April 2026
GLP-1 Drugs to Reduce Symptoms in People with ME/CFS and Identify Disease Subgroups

April 16 @ 8:30 am - 9:30 am PDT

Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels. Thus, these medicines help control blood sugar […]

Free
The Discovery of Target Antigens for Dysfunctional T Cells in ME/CFS and Long COVID

April 28 @ 3:00 pm - 4:00 pm PDT

Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst Award for their study searching for the exact proteins recognized by T-cell receptors from a […]

Free
June 2026
Sequence ME & Long Covid: The Search for ME/CFS and Long Covid Biomarkers and Subtypes

June 10 @ 11:00 am - 12:00 pm PDT

The DecodeME Project is the largest genetic study of ME/CFS conducted to date and has identified eight genetic signals where people with ME/CFS tend to differ from those without, linked to the immune and nervous systems. These landmark findings reflect the lived experience of thousands of people with ME/CFS, providing validation and exciting new avenues for […]
July 2026
Repurposing Rapamycin: A Report On the First Biomarker-Driven Treatment Trial for ME/CFS

July 14 @ 3:00 pm - 4:00 pm PDT

In 2025, Simmaron Research was the second recipient of Solve’s ME/CFS Catalyst Award in support of its study, “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” The study hypothesizes that mTOR inhibition through rapamycin may address observed findings of autophagy impairment and symptoms in a subset of patients with ME/CFS and other […]
August 2026
“Coffee With a Clinician” in Recognition of Severe M.E. Awareness Month

August 12 @ 9:00 am - 10:00 am PDT

Solve M.E. is proud to join our hosts from the Bateman Horne Center for a special edition of their program "Coffee with a Clinician" in observance of Severe ME/CFS Awareness […]

Free
September 2026
A Safe, Accessible Treatment for ME/CFS? The Mitochondrial Stabilizer IVO-21 Study

September 8 @ 3:00 pm - 4:00 pm PDT

As part of our commitment to advancing science that brings real hope to people living with ME/CFS or Long Covid, Solve has selected Dr. Jay H. Chung (National Institutes of […]

October 2025

January 2026

April 2026

June 2026

July 2026

August 2026

September 2026